Table 2.

Descriptive statistics regarding the annotation of CONSORT checklist items in CONSORT-TM. SD: standard deviation.

CONSORT Item	No. of articles	Avg. number of sentences per article (±SD)	Range
Title Randomized (1a)	40	0.80 (±0.40)	0–1
Structured Abstract (1b)	49	0.98 (±0.14)	0–1
Background (2a)	50	2.04 (±0.20)	2–3
Objectives (2b)	50	1.44 (±0.61)	1–3
Trial Design (3a)	49	1.48 (±0.95)	0–5
Changes to Trial Design (3b)	4	0.20 (±0.70)	0–3
Eligibility Criteria (4a)	49	3.20 (±1.56)	0–8
Data Collection Setting (4b)	40	0.96 (±0.60)	0–2
Interventions (5)	50	5.40 (±3.17)	1–15
Outcomes (6a)	50	13.22 (±7.24)	3–38
Changes to Outcomes (6b)	5	0.12 (±0.39)	0–2
Sample Size Determination (7a)	46	2.26 (±1.65)	0–8
Interim Analyses/ Stopping Guidelines (7b)	11	0.42 (±1.01)	0–5
Sequence Generation (8a)	38	0.86 (±0.61)	0–3
Randomization Type (8b)	39	1.00 (±0.70)	0–3
Allocation Concealment (9)	19	0.44 (±0.64)	0–3
Randomization Implementation (10)	30	1.14 (±1.51)	0–8
Blinding (11a)	40	1.18 (±1.38)	0–9
Similarity of Interventions (11b)	15	0.36 (±0.60)	0–2
Statistical Methods for Outcomes (12a)	50	5.44 (±2.60)	1–13
Statistical Methods for Other Analyses (12b)	29	1.44 (±1.67)	0–6
Participant Flow (13a)	45	2.52 (±1.39)	0–6
Participant Loss/Exclusion (13b)	43	2.32 (±1.65)	0–7
Periods of Recruitment/ Follow-Up (14a)	42	1.04 (±0.67)	0–3
Trial Stopping (14b)	6	0.18 (±0.63)	0–4
Baseline Data (15)	50	3.80 (±2.24)	1–12
Numbers Analyzed (16)	47	2.06 (±1.43)	0–7
Outcome Results (17a)	50	14.38 (±8.89)	2–48
Binary Outcome Results (17b)	32	3.94 (±5.59)	0–26
Ancillary Analyses (18)	37	4.50 (±4.46)	0–16
Harms (19)	45	3.88 (±3.90)	0–17
Limitations (20)	44	4.16 (±2.97)	0–11
Generalizability (21)	29	0.88 (±0.98)	0–4
Interpretation (22)	50	13.00 (±6.74)	3–40
Registration (23)	45	1.20 (±0.61)	0–2
Protocol Access (24)	7	0.16 (±0.42)	0–2
Funding (25)	50	2.52 (±1.82)	1–10